Saturday 17 October 2026 Export TVRD’s income statement to Excel — free account

Tvardi Therapeutics, Inc.

In the quarter to June 2026, revenue grew 20.3%, EPS fell 235.3% and free cash flow fell 57.3%, each against the same quarter a year earlier.

1.01 0.06 −5.61%

Follow TVRD

Alert me

Market cap: $14.3M
P/E: 0.0×
Fwd P/E: −0.5×
Dividend yield: —
F-score: 3/9
Altman Z: −5.15
Beneish M: −3.66
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	19.93%	51.90%	(480.07%)	(126.19%)
ROA Full definition →		6.30%	(54.15%)	(47.68%)	(85.08%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		10.37%	(88.64%)	(109.40%)	(326.11%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(2.42)	(3.17)	(2.31)	(2.67)
Free Cash Flow Full definition →		(22.65)	(23.50)	(21.67)	(25.03)
Other line items
Cash ROIC Full definition →		(35.21%)	(45.40%)	(54.88%)	(103.65%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	(0.43)	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		(7.95)	1.29	1.40	0.96
Depreciation/Fixed assets Full definition →		1.58	(2.02)	(2.39)	(2.92)
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(2.42)	(3.17)	(2.31)	(2.67)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly